[Antituberculosis chemoprophylaxis in a public hospital - study of 100 children]

Clemax C. Sant'Anna1, Solange G. David, Anna M. Marques

  • 1Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

Jornal De Pediatria
|December 3, 2003
PubMed

Insights

This study evaluated tuberculosis chemoprophylaxis in children, finding that while 15% adhered to guidelines, 85% were prescribed treatment for high-risk groups. Adherence to national guidelines for pediatric tuberculosis prevention needs improvement.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Antituberculosis chemoprophylaxis is crucial for preventing active tuberculosis in children, especially those exposed to infected individuals or with specific risk factors.
  • National guidelines aim to standardize chemoprophylaxis, but adherence and effectiveness in diverse pediatric populations require evaluation.
  • Special considerations exist for very young children, BCG-vaccinated children with positive tuberculin skin tests, and those with recent or current exposure to tuberculosis.

Purpose of the Study:

  • To assess the adherence to National Tuberculosis Control Program guidelines for antituberculosis chemoprophylaxis in children.
  • To evaluate the application of these recommendations in special pediatric situations, including high-risk groups.
  • To analyze factors influencing chemoprophylaxis outcomes, such as adherence, monotherapy failure, and side effects.

Main Methods:

  • A retrospective cross-sectional study was conducted on 100 children receiving chemoprophylaxis at a public hospital in Rio de Janeiro.
  • Data collected included demographics, BCG vaccination status, nutritional status, tuberculin skin test results, tuberculosis exposure, and treatment adherence.
  • Analysis focused on adherence to guidelines, identification of infection sources, monotherapy failure rates, and isoniazid side effects.

Main Results:

  • The study included 57% males and 43% females; 62% were under five years old.
  • 92% had prior BCG vaccination, 28% presented with malnutrition, and 9% were recent tuberculosis converters.
  • Parents were the source of infection in 60% of known cases; 73% adhered to chemoprophylaxis, with 1% experiencing monotherapy failure and 1% reporting isoniazid side effects.

Conclusions:

  • Only 15% of children fully followed Health Department guidelines, including those with recent tuberculosis converters.
  • The majority (85%) of recommended chemoprophylaxis was administered to cover high-risk pediatric groups.
  • Findings suggest a need to improve adherence to established national guidelines for pediatric tuberculosis chemoprophylaxis, particularly for vulnerable populations.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...